announced today that the United States Food and Medication Administration informed CTI that due to severe climate in the Washington, D.C. Region, the FDA is postponing the Oncologic Medications Advisory Committee conference that was to be held on Wednesday, 10 February, 2010 to discuss the pixantrone New Drug Program . The FDA indicated that it intends to reschedule the achieving as soon as the FDA can determine a schedule that will allow them to reconvene the advisory panel.Theoretically, blocking quorum sensing would avoid the bacterias from turning pathogenic and creating the poisons that are an instantaneous reason behind disease in bacterial attacks. Bacteria use simple chemical substance signals to regulate quorum sensing, and Blackwell is normally thinking about how these compounds function and in developing fresh methods to intercept them. In a report released online in the journal ChemBioChem just, Blackwell and co-workers Andrew Palmer, Evan Streng and Kelsea Jewell showed that many species of bacterias can react to identical signals, suggesting that one medication could fight quorum sensing in a number of types of bacterias.